Ultrastructural relationship between the AMPA-GluR2 receptor subunit and the mu-opioid receptor in the mouse central nucleus of the amygdala

Experimental Neurology

Volumn 227, Issue 1, 2011, Pages 149-158

  Beckerman, Marc A ^a   Glass, Michael J ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Addiction; Glutamate; Opioids; Synaptic plasticity

Indexed keywords

AMPA RECEPTOR; CALCIUM; GLUTAMATE RECEPTOR 2; MU OPIATE RECEPTOR; OPIATE; PEROXIDASE;

AFFECT; AMYGDALOID NUCLEUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR; CELL COMPARTMENTALIZATION; CELL MEMBRANE PERMEABILITY; CELL STRUCTURE; CELL VACUOLE; CONTROLLED STUDY; DENDRITE; DRUG DEPENDENCE; ELECTRON MICROSCOPY; IMMUNOCYTOCHEMISTRY; IMMUNOGOLD LABELING; MALE; MOUSE; NERVE CELL MEMBRANE; NERVE CELL PLASTICITY; NERVE ENDING; NONHUMAN; POSTSYNAPTIC POTENTIAL; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; SENSORY NERVE; SIGNAL TRANSDUCTION; SYNAPSE; ULTRASTRUCTURE;

AMYGDALA; ANIMALS; DENDRITES; MALE; MICE; MICE, INBRED C57BL; MICROSCOPY, IMMUNOELECTRON; NEURONS; PROTEIN SUBUNITS; RECEPTORS, AMPA; RECEPTORS, OPIOID, MU;

EID: 78650965133     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2010.10.010     Document Type: Article

References (57)

1. Asan E. The catecholaminergic innervation of the rat amygdala. Advances in Anat., Embryol., Cell Biol 1998, 142:1-118.
2. Bassani S., Valnegri P., Beretta F., Passafaro M. The GLUR2 subunit of AMPA receptors: synaptic role. Neuroscience 2009, 158:55-61.
3. Blazer L.L., Neubig R.R. Small molecule protein-protein interaction inhibitors as CNS therapeutic agents: current progress and future hurdles. Neuropsychopharmacology 2009, 34:126-141.
4. Bockaert J., Perroy J., Becamel C., Marin P., Fagni L. GPCR interacting proteins (GIPs) in the nervous system: roles in physiology and pathologies. Annu. Rev. Pharmacol. Toxicol. 2010, 50:89-109.
5. Bouvier M. Oligomerization of G-protein-coupled transmitter receptors. Nat. Rev. Neurosci. 2001, 2:274-286.
6. Carlezon W.A.J., Rasmussen K., Nestler E.J. AMPA antagonist LY293558 blocks the development, without blocking the expression, of behavioral sensitization to morphine. Synapse 1999, 31:256-262.
7. Cassell M.D., Gray T.S. Morphology of peptide-immunoreactive neurons in the rat central nucleus of the amygdala. J. Comp. Neurol. 1989, 281:320-333.
8. Chan J., Aoki C., Pickel V.M. Optimization of differential immunogold-silver and peroxidase labeling with maintenance of ultrastructure in brain sections before plastic embedding. J. Neurosci. Methods 1990, 33:113-127.
9. 2+-permeable AMPA receptors: synaptic plasticity and beyond. Curr. Opin. Neurobiol. 2006, 16:288-297.
10. Cullinan W.E., Herman J.P., Watson S.J. Ventral subicular interaction with the hypothalamic paraventricular nucleus: evidence for a relay in the bed nucleus of the stria terminalis. J. Comp. Neurol. 1993, 332:1-20.
11. Drake C.T., Milner T.A. Mu opioid receptors are in discrete hippocampal interneuron subpopulations. Hippocampus 2002, 12:119-136.
12. Fabian-Fine R., Volknandt W., Fine A., Stewart M.G. Age-dependent pre- and postsynaptic distribution of AMPA receptors at synapses in CA3 stratum radiatum of hippocampal slice cultures compared with intact brain. Eur. J. Neurosci. 2000, 12:3687-3700.
13. Fallon J.H., Leslie F.M. Distribution of dynorphin and enkephalin peptides in the rat brain. J. Comp. Neurol. 1986, 249:293-336.
14. Fisk G.D., Wyss J.M. Descending projections of infralimbic cortex that mediate stimulation-evoked changes in arterial pressure. Brain Res. 2000, 859:83-95.
15. Garzon J., Rodriguez-Munoz M., Lopez-Fando A., Garcia-Espana A., Sanchez-Blazquez P. RGSZ1 and GAIP regulate mu- but not delta-opioid receptors in mouse CNS: role in tachyphylaxis and acute tolerance. Neuropsychopharmacology 2004, 29:1091-1104.
16. Glass M.J. The role of functional postsynaptic NMDA receptors in the central nucleus of the amygdala in opioid dependence. Vitam. Horm. 2010, 82:145-166.
17. Glass M.J., Vanyo L., Quimson L., Pickel V.M. Ultrastructural relationship between NMDA-NR1 and mu-opioid receptor in the mouse central nucleus of the amygdala. Neuroscience 2009, 163:857-867.
18. Greger I.H., Esteban J.A. AMPA receptor biogenesis and trafficking. Curr. Opin. Neurobiol. 2007, 17:289-297.
19. Hara Y., Pickel V.M. Preferential relocation of the N-methyl-d-aspartate receptor NR1 subunit in nucleus accumbens neurons that contain dopamine D1 receptors in rats showing an apomorphine-induced sensorimotor gating deficit. Neuroscience 2008, 154:965-977.
20. He Y., Janssen W.G., Morrison J.H. Synaptic coexistence of AMPA and NMDA receptors in the rat hippocampus: a postembedding immunogold study. J. Neurosci. Res. 1998, 54:444-449.
21. He Y., Janssen W.G., Morrison J.H. Differential synaptic distribution of the AMPA-GluR2 subunit on GABAergic and non-GABAergic neurons in the basolateral amygdala. Brain Res. 1999, 827:51-62.
22. Hof P.R., Young E.G., Bloom F.E., Belichenko P.V., Celio M.R. Comparative Cytoarchitectonic Atlas of the C57BL/6 and 129/SV Mouse Brains 2000, Elsevier.
23. Jaferi A., Pickel V.M. Mu-opioid and corticotropin-releasing-factor receptors show largely postsynaptic co-expression, and separate presynaptic distributions, in the mouse central amygdala and bed nucleus of the stria terminalis. Neuroscience 2009, 159:526-539.
24. Kawasaki Y., Jin C., Suemaru K., Kawasaki H., Shibata K., Choshi T., Hibino S., Gomita Y., Araki H. Effect of glutamate receptor antagonists on place aversion induced by naloxone in single-dose morphine-treated rats. Br. J. Pharmacol. 2005, 145:751-757.
25. Kishi T., Tsumori T., Yokota S., Yasui Y. Topographical projection from the hippocampal formation to the amygdala: a combined anterograde and retrograde tracing study in the rat. J. Comp. Neurol. 2006, 496:349-368.
26. Klein G., Juni A., Arout C.A., Waxman A.R., Inturrisi C.E., Kest B. Acute and chronic heroin dependence in mice: contribution of opioid and excitatory amino acid receptors. Eur. J. Pharmacol. 2008, 586:179-188.
27. Knapska E., Radwanska K., Werka T., Kaczmarek L. Functional internal complexity of amygdala: focus on gene activity mapping after behavioral training and drugs of abuse. Physiol. Rev. 2007, 87:1113-1173.
28. Koob G.F., Volkow N.D. Neurocircuitry of addiction. Neuropsychopharmacology 2010, 35:217-238.
29. Lang P.J., Davis M. Emotion, motivation, and the brain: reflex foundations in animal and human research. Prog. Brain Res. 2006, 156:3-29.
30. Layer R.T., Uretsky N.J., Wallace L.J. Effects of the AMPA/kainate receptor antagonist DNQX in the nucleus accumbens on drug-induced conditioned place preference. Brain Res. 1993, 617.
31. LeDoux J.E. Emotion circuits in the brain. Ann. Rev. Neurosci. 2000, 23:155-184.
32. Leranth C., Pickel V.M. Electron microscopic pre-embedding double immunostaining methods. Tract tracing methods 2, recent progress 1989, 129-172. Plenum, New York. L. Heimer, L. Zaborszky (Eds.).
33. 2+ permeability of glutamate receptor channels in hippocampal cells. Eur. J. Neurosci. 1994, 6:1080-1088.
34. Mansour A., Fox C.A., Akil H., Watson S.J. Opioid-receptor mRNA expression in the rat CNS: anatomical and functional implications. Trends Neurosci. 1995, 18:22-29.
35. Mansour A., Khachaturian H., Lewis M.E., Akil H., Watson S.J. Anatomy of CNS opioid receptors. Trends Neurosci. 1988, 11:308-314.
36. McDonald A.J. Cortical pathways to the mammalian amygdala. Prog. Neurobiol. 1998, 55:257-332.
37. Mead A.N., Morris H.V., Dixon C.I., Rulten S.L., Mayne L.V., Zamanillo D., Stephens D.N. AMPA receptor GluR2, but not GluR1, subunit deletion impairs emotional response conditioning in mice. Behav. Neurosci. 2006, 120:241-248.
38. Migues P.V., Hardt O., Wu D.C., Gamache K., Sacktor T.C., Wang Y.T., Nader K. PKMzeta maintains memories by regulating GluR2-dependent AMPA receptor trafficking. Nat. Neurosci. 2010, 13:630-634.
39. Palmer C.L., Cotton L., Henley J.M. The molecular pharmacology and cell biology of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors. Pharmacol. Rev. 2005, 57:253-277.
40. Peters A., Palay S.L., Webster H. The Fine Structure of the Nervous System 1991, Oxford University Press.
41. Petralia R.S., Wang Y.X., Mayat E., Wenthold R.J. Glutamate receptor subunit 2-selective antibody shows a differential distribution of calcium-impermeable AMPA receptors among populations of neurons. J. Comp. Neurol. 1997, 385:456-476.
42. Petralia R.S., Wenthold R.J. Light and electron immunocytochemical localization of AMPA-selective glutamate receptors in the rat brain. J. Comp. Neurol. 1992, 318:329-354.
43. Pitkanen A., Savander V., LeDoux J.E. Organization of intra-amygdaloid circuitries in the rat: an emerging framework for understanding functions of the amygdala. Trends Neurosci. 1997, 20:517-523.
44. Poulin J.F., Chevalier B., Laforest S., Drolet G. Enkephalinergic afferents of the centromedial amygdala in the rat. J. Comp. Neurol. 2006, 496:859-876.
45. Rasmussen K., Vandergriff J. The selective iGluR1-4 (AMPA) antagonist LY300168 attenuates morphine-withdrawal-induced activation of locus coeruleus neurons and behavioural signs of morphine withdrawal. Neuropharmacology 2003, 44:88-92.
46. Sacktor T.C. PKMzeta, LTP maintenance, and the dynamic molecular biology of memory storage. Prog. Brain Res. 2008, 169:27-40.
47. Sato K., Kiyama H., Tohyama M. The differential expression patterns of messenger RNAs encoding non-N-methyl-d-aspartate glutamate receptor subunits (GluR1-4) in the rat brain. Neuroscience 1993, 52:515-539.
48. Sepehrizadeh Z., Bahrololoumi Shapourabadi M., Ahmadi S., Hashemi Bozchlou S., Zarrindast M.R., Sahebgharani M. Decreased AMPA GluR2, but not GluR3, mRNA expression in rat amygdala and dorsal hippocampus following morphine-induced behavioural sensitization. Clin. Exp. Pharmacol. Physiol. 2008, 35:1321-1330.
49. Shindou T., Watanabe S., Yamamoto K., Nakanishi H. NMDA receptor-dependent formation of long-term potentiation in the rat medial amygdala neuron in an in vitro slice preparation. Brain Res. Bull. 1993, 31:667-672.
50. Spruston N., Jonas P., Sakmann B. Dendritic glutamate receptor channels in rat hippocampal CA3 and CA1 pyramidal neurons. J. Physiol. 1995, 482:325-352.
51. Taylor J.R., Punch L.R., Elsworth J.D. A comparison of the effects of clonidine and CNQX infusion into the locus coeruleus and the amygdala on naloxone-precipitated opiate withdrawal in the rat. Psychopharmacology 1998, 138:133-142.
52. Turner B.H., Herkenham M. Thalamoamygdaloid projections in the rat: a test of the amygdala's role in sensory processing. J. Comp. Neurol. 1991, 313:295-325.
53. Tzschentke T.M., Schmidt W.J. Interactions of MK-801 and GYKI 52466 with morphine and amphetamine in place preference conditioning and behavioural sensitization. Behav. Brain Res. 1997, 84:99-107.
54. Van den Oever M.C., Goriounova N.A., Li K.W., Van der Schors R.C., Binnekade R., Schoffelmeer A.N., Mansvelder H.D., Smit A.B., Spijker S., De Vries T.J. Prefrontal cortex AMPA receptor plasticity is crucial for cue-induced relapse to heroin-seeking. Nat. Neurosci. 2008, 11:1053-1058.
55. Wang H., Cuzon V.C., Pickel V.M. Postnatal development of mu-opioid receptors in the rat caudate-putamen nucleus parallels asymmetric synapse formation. Neuroscience 2003, 118:695-708.
56. Watanabe T., Nakagawa T., Yamamoto R., Maeda A., Minami M., Satoh M. Involvement of glutamate receptors within the central nucleus of the amygdala in naloxone-precipitated withdrawal-induced conditioned place aversion in rats. Jpn J. Pharmacol. 2002, 88:399-406.
57. Zhong W., Dong Z., Tian M., Cao J., Xu T., Xu L., Luo J. Opiate withdrawal induces dynamic expressions of AMPA receptors and its regulatory molecule CaMKIIalpha in hippocampal synapses. Life Sci. 2006, 79:861-869.